Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/2072
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Buntinx, F | - |
dc.contributor.author | Wachana, R | - |
dc.contributor.author | Bartholomeeusen, Stefaan | - |
dc.contributor.author | Sweldens, K | - |
dc.contributor.author | GEYS, Helena | - |
dc.date.accessioned | 2007-11-11T09:58:25Z | - |
dc.date.available | 2007-11-11T09:58:25Z | - |
dc.date.issued | 2005 | - |
dc.identifier.citation | BRITISH JOURNAL OF GENERAL PRACTICE, 55(511). p. 102-107 | - |
dc.identifier.issn | 0960-1643 | - |
dc.identifier.uri | http://hdl.handle.net/1942/2072 | - |
dc.description.abstract | Background It has been suggested that herpes zoster may be a marker for occult malignancy. Aim To examine the emergence of a subsequent cancer diagnosis in patients with and without herpes zoster. Design of study Retrospective cohort study. Setting Results were based on the database of Intego, an ongoing Belgian general practice-based morbidity registry, covering 37 general practitioners and including about 311 000 patient years between the years 1994 and 2000. Method Survival analysis comparing the emergence of malignancy in patients with and without herpes zoster. Results The number of patients below the age of 65 years with herpes zoster, cancer or both was too low to draw any sensible conclusions. Above the age of 65 years we identified a significant increase of cancer emergence in the whole group and in females (hazard ratio = 2.65, 95% confidence interval = 1.43 to 4.90), but not in males. No difference could be identified in the first year after the herpes zoster infection. Conclusion Our results do not justify extensive testing for cancer in herpes zoster patients. The association we identified, however, leaves open a number of questions with respect to the physiopathology behind it. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ROYAL COLL GENERAL PRACTITIONERS | - |
dc.subject.other | cohort studies; herpes zoster; neoplasm; survival analysis | - |
dc.title | Is herpes zoster a marker for occult or subsequent malignancy? | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 107 | - |
dc.identifier.issue | 511 | - |
dc.identifier.spage | 102 | - |
dc.identifier.volume | 55 | - |
local.format.pages | 6 | - |
local.bibliographicCitation.jcat | A1 | - |
dc.description.notes | Univ Leuven, Dept Gen Practice, B-3000 Louvain, Belgium. Univ Maastricht, Inst Res, Maastricht, Netherlands. Limburgs Univ Ctr, Ctr Stat, Diepenbeek, Belgium. Med Ctr Hurarten, Louvain, Belgium.Buntinx, F, Univ Leuven, Dept Gen Practice, Kapucijnenvoer 33,Blok J, B-3000 Louvain, Belgium.Frank.buntinx@med.kuleuven.ac.be | - |
local.type.refereed | Refereed | - |
local.type.specified | Article | - |
dc.bibliographicCitation.oldjcat | A1 | - |
dc.identifier.isi | 000227990000007 | - |
dc.identifier.url | http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1463183&rendertype=abstract | - |
item.fullcitation | Buntinx, F; Wachana, R; Bartholomeeusen, Stefaan; Sweldens, K & GEYS, Helena (2005) Is herpes zoster a marker for occult or subsequent malignancy?. In: BRITISH JOURNAL OF GENERAL PRACTICE, 55(511). p. 102-107. | - |
item.contributor | Buntinx, F | - |
item.contributor | Wachana, R | - |
item.contributor | Bartholomeeusen, Stefaan | - |
item.contributor | Sweldens, K | - |
item.contributor | GEYS, Helena | - |
item.validation | ecoom 2006 | - |
item.fulltext | No Fulltext | - |
item.accessRights | Closed Access | - |
crisitem.journal.issn | 0960-1643 | - |
crisitem.journal.eissn | 1478-5242 | - |
Appears in Collections: | Research publications |
WEB OF SCIENCETM
Citations
24
checked on Apr 16, 2024
Page view(s)
30
checked on Jul 31, 2023
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.